Špela Gruden

Dr. Špela Gruden


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2026 in Foods
Verified
Journal Article
Open access
PDF file
ŠGŠpela Gruden
Špela Gruden
PLPetra Mohar Lorbeg
Petra Mohar Lorbeg
Bojana Bogovič MatijašićBojana Bogovič Matijašić
Bojana Bogovič Matijašić
Mihaela SkrtMihaela Skrt
Mihaela Skrt
ALAdrijana Leonardi
Adrijana Leonardi
Natasa Poklar UlrihNatasa Poklar Ulrih
Natasa Poklar Ulrih
Lactoferrin (Lf) and Lf-derived peptides are multifunctional milk components with potential applications in food preservation due to their antibacterial and antioxidant properties. In this study, the antibacterial and antioxidant activities of bovine lactoferrin and Lf-derived peptides obtained by enzymatic hydrolysis with pepsin, trypsin, and chymotrypsin were evaluated. Antibacterial activity was assessed against four foodborne pathogens and spoilage microorganisms (Escherichia coli, Listeria monocytogenes, Staphylococcus epidermidis, and Latilactobacillus sakei), while antioxidant activity was determined using four complementary assays. Lf showed stronger antibacterial activity than the corresponding hydrolysates against all tested strains, while the hydrolysates notably inhibited Listeria monocytogenes and Latilactobacillus sakei. Both Lf and its peptides showed lower antioxidant capacity than Trolox, although native Lf and its peptides markedly inhibited lipid peroxidation. Lf peptides demonstrated greater antioxidant activity in the superoxide scavenging and FRAP assays. Low-molecular-weight peptides (<10 kDa) contributed most to antioxidant activity, while mass spectrometry analysis revealed peptide sequences rich in hydrophobic and electron-donating amino acid residues, providing mechanistic insight into the observed activities. Overall, these findings highlight the potential of lactoferrin and its enzymatic hydrolysates as natural antimicrobial and antioxidant agents for food preservation.

4 October 2026 in Human Genomics
Verified
Journal Article
Open access
PDF file
ŠGŠpela Gruden
Špela Gruden
LDLucija Raspor DallOlio
Lucija Raspor DallOlio
JHJohn M. Hancock
John M. Hancock
AZAlja Zottel
Alja Zottel
CSCene Skubic
Cene Skubic
DRDamjana Rozman
Damjana Rozman
Advances in high-throughput sequencing technologies have transformed human genomics, enabling large-scale initiatives to characterise genome structure, function, and population diversity. Following foundational international projects such as the Human Genome Project, HapMap, and the 1000 Genomes Project, many countries have developed national sequencing initiatives to generate population-specific genomic resources and support precision medicine. In this review, we examine the development of human genomic sequencing initiatives with a particular focus on Europe, where national projects differ substantially in their objectives, infrastructure, governance, funding models, cohort design, and degree of integration with healthcare systems. We further consider how pan-European programmes are increasingly linking these heterogeneous national efforts through shared standards, federated data infrastructures, and coordinated population-reference initiatives. Comparisons with selected initiatives from other world regions highlight common challenges, including unequal population representation, long-term sustainability, data governance, interoperability, and translation into clinical practice. We also discuss the growing impact of long-read sequencing and artificial intelligence on population genomics and genomic medicine. Overall, the European landscape illustrates that successful genomic initiatives depend not simply on sequencing scale, but on the alignment of scientific objectives with representative recruitment, sustainable infrastructure and financing, interoperable data systems, and pathways for clinical implementation.